393 related articles for article (PubMed ID: 36726813)
1. Older Adults and Immune Thrombocytopenia: Considerations for the Clinician.
Crickx E; Mahévas M; Michel M; Godeau B
Clin Interv Aging; 2023; 18():115-130. PubMed ID: 36726813
[TBL] [Abstract][Full Text] [Related]
2. How we manage immune thrombocytopenia in the elderly.
Mahévas M; Michel M; Godeau B
Br J Haematol; 2016 Jun; 173(6):844-56. PubMed ID: 27062054
[TBL] [Abstract][Full Text] [Related]
3. Management of immune thrombocytopenia in elderly patients.
Lucchini E; Fanin R; Cooper N; Zaja F
Eur J Intern Med; 2018 Dec; 58():70-76. PubMed ID: 30274902
[TBL] [Abstract][Full Text] [Related]
4. Current and emerging treatments for immune thrombocytopenia.
Dou X; Yang R
Expert Rev Hematol; 2019 Sep; 12(9):723-732. PubMed ID: 31237783
[No Abstract] [Full Text] [Related]
5. [Diagnostic approach and treatment of immune thrombocytopenia in adults].
Kolonić SO; Patekar MB; Milunović V
Acta Med Croatica; 2013 Mar; 67(1):3-11. PubMed ID: 24279250
[TBL] [Abstract][Full Text] [Related]
6. Contemporary management of primary immune thrombocytopenia in adults.
Lakshmanan S; Cuker A
J Thromb Haemost; 2012 Oct; 10(10):1988-98. PubMed ID: 22863415
[TBL] [Abstract][Full Text] [Related]
7. Consensus guidelines for the management of adult immune thrombocytopenia in Australia and New Zealand.
Choi PY; Merriman E; Bennett A; Enjeti AK; Tan CW; Goncalves I; Hsu D; Bird R
Med J Aust; 2022 Jan; 216(1):43-52. PubMed ID: 34628650
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of ITP and AIHA in CVID: A systematic literature review].
Lacombe V; Lozac'h P; Orvain C; Lavigne C; Miot C; Pellier I; Urbanski G
Rev Med Interne; 2019 Aug; 40(8):491-500. PubMed ID: 31101329
[TBL] [Abstract][Full Text] [Related]
9. Current approaches for the diagnosis and management of immune thrombocytopenia.
Gafter-Gvili A
Eur J Intern Med; 2023 Feb; 108():18-24. PubMed ID: 36424271
[TBL] [Abstract][Full Text] [Related]
10. Immune Thrombocytopenia in Children: Consensus and Controversies.
Singh G; Bansal D; Wright NAM
Indian J Pediatr; 2020 Feb; 87(2):150-157. PubMed ID: 31927692
[TBL] [Abstract][Full Text] [Related]
11. ITP and international guidelines: what do we know, what do we need?
Rodeghiero F; Ruggeri M
Presse Med; 2014 Apr; 43(4 Pt 2):e61-7. PubMed ID: 24656296
[TBL] [Abstract][Full Text] [Related]
12. Treatment patterns and outcomes of second-line rituximab and thrombopoietin receptor agonists in adult immune thrombocytopenia: A Canadian retrospective cohort study.
Podstawka J; Wall E; Bolster L; Patterson JM; Goodyear MD; Rydz N; Sun HL
Thromb Res; 2022 Dec; 220():5-11. PubMed ID: 36257098
[TBL] [Abstract][Full Text] [Related]
13. A multicenter retrospective analysis on therapeutic plasma exchange in immune thrombocytopenic purpura.
Basturk A; Sayin S; Erkurt MA; Sarici A; Ekinci O; Kum A; Berber I; Korkmaz S; Dogan A; Ulas T; Kuku I; Eser B; Altuntas F
Transfus Apher Sci; 2021 Oct; 60(5):103246. PubMed ID: 34419359
[TBL] [Abstract][Full Text] [Related]
14. Risk factors of hospitalisation for thrombosis in adults with primary immune thrombocytopenia, including disease-specific treatments: a French nationwide cohort study.
Lafaurie M; Maquet J; Baricault B; Ekstrand C; Christiansen CF; Linder M; Bahmanyar S; Nørgaard M; Sailler L; Lapeyre-Mestre M; Sommet A; Moulis G
Br J Haematol; 2021 Nov; 195(3):456-465. PubMed ID: 34386974
[TBL] [Abstract][Full Text] [Related]
15. Immune thrombocytopenia.
Bussel J; Cooper N; Boccia R; Zaja F; Newland A
Expert Rev Hematol; 2021 Nov; 14(11):1013-1025. PubMed ID: 34720027
[TBL] [Abstract][Full Text] [Related]
16. A proposal for new definition (s) and management approach to paediatric refractory ITP: Reflections from the Intercontinental ITP Study Group.
Neunert C; Heitink-Polle KMJ; Lambert MP
Br J Haematol; 2023 Oct; 203(1):17-22. PubMed ID: 37641973
[TBL] [Abstract][Full Text] [Related]
17. Updated guidelines for immune thrombocytopenic purpura: Expanded management options.
DeSouza S; Angelini D
Cleve Clin J Med; 2021 Dec; 88(12):664-668. PubMed ID: 34857604
[TBL] [Abstract][Full Text] [Related]
18. Current Understanding of Immune Thrombocytopenia: A Review of Pathogenesis and Treatment Options.
Mititelu A; Onisâi MC; Roșca A; Vlădăreanu AM
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396839
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis and treatment of immune thrombocytopenia.
Červinek L
Vnitr Lek; 2018; 64(5):526-529. PubMed ID: 30193522
[TBL] [Abstract][Full Text] [Related]
20. [Epidemiology and pharmacoepidemiology of immune thrombocytopenia].
Moulis G; Lapeyre-Mestre M; Adoue D; Sailler L
Rev Med Interne; 2017 Jul; 38(7):444-449. PubMed ID: 28131440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
